FindTrial
Sign In

AKP-008 Clinical Study

AKP-008 Clinical Study

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080222248
Enrollment
Unknown
Registered
2013-10-04
Start date
2013-10-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Luteal phase support after in-vitro fertilization

Interventions

investigational material(s) Generic name etc : AKP-008 INN of investigational material : Progesterone Therapeutic category code : 247 Estrogen and gestagen preparations Dosage and Administration for I

Sponsors

ASKA Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: -Female partners of infertile married couples who want to conceive -BMI<30

Exclusion criteria

Exclusion criteria: -Subjects with intraperitoneal abnormalities interfering with transvaginal ultrasound -Subjects with uterine cavity abnormalities that preclude pregnancy -Subjects with serious liver disorders or disease

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy rate and safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026